Steven Barker Sells 10,000 Shares of Masimo Corporation (MASI) Stock
Masimo Corporation (NASDAQ:MASI) Director Steven Barker sold 10,000 shares of Masimo Corporation stock in a transaction that occurred on Wednesday, November 1st. The stock was sold at an average price of $90.00, for a total transaction of $900,000.00. Following the sale, the director now owns 73,249 shares of the company’s stock, valued at approximately $6,592,410. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website.
Masimo Corporation (MASI) traded down $1.93 during trading on Friday, reaching $86.00. 261,418 shares of the company traded hands, compared to its average volume of 384,306. The firm has a market capitalization of $4.37 billion, a P/E ratio of 32.37 and a beta of 0.75.
Masimo Corporation (NASDAQ:MASI) last released its quarterly earnings data on Tuesday, October 31st. The medical equipment provider reported $0.70 earnings per share for the quarter, topping the consensus estimate of $0.53 by $0.17. Masimo Corporation had a net margin of 45.83% and a return on equity of 22.17%. The business had revenue of $193.69 million for the quarter, compared to analyst estimates of $189.01 million. During the same quarter last year, the firm earned $0.52 EPS. Masimo Corporation’s quarterly revenue was up 15.6% compared to the same quarter last year. equities research analysts predict that Masimo Corporation will post 2.96 EPS for the current fiscal year.
ILLEGAL ACTIVITY NOTICE: “Steven Barker Sells 10,000 Shares of Masimo Corporation (MASI) Stock” was published by American Banking News and is the property of of American Banking News. If you are reading this piece of content on another site, it was illegally stolen and republished in violation of U.S. & international copyright laws. The legal version of this piece of content can be viewed at https://www.americanbankingnews.com/2017/11/03/steven-barker-sells-10000-shares-of-masimo-corporation-masi-stock.html.
A number of institutional investors and hedge funds have recently made changes to their positions in MASI. BlackRock Inc. lifted its stake in Masimo Corporation by 7.5% in the second quarter. BlackRock Inc. now owns 7,915,230 shares of the medical equipment provider’s stock valued at $721,710,000 after buying an additional 550,995 shares in the last quarter. Koch Industries Inc. lifted its stake in Masimo Corporation by 5,053.7% in the second quarter. Koch Industries Inc. now owns 443,939 shares of the medical equipment provider’s stock valued at $439,000 after buying an additional 435,325 shares in the last quarter. State Street Corp lifted its stake in Masimo Corporation by 42.8% in the first quarter. State Street Corp now owns 1,401,516 shares of the medical equipment provider’s stock valued at $130,704,000 after buying an additional 419,767 shares in the last quarter. Acadian Asset Management LLC lifted its stake in Masimo Corporation by 28.0% in the second quarter. Acadian Asset Management LLC now owns 1,791,597 shares of the medical equipment provider’s stock valued at $163,356,000 after buying an additional 392,410 shares in the last quarter. Finally, JPMorgan Chase & Co. lifted its stake in Masimo Corporation by 76.3% in the second quarter. JPMorgan Chase & Co. now owns 802,698 shares of the medical equipment provider’s stock valued at $73,191,000 after buying an additional 347,360 shares in the last quarter. 82.96% of the stock is currently owned by hedge funds and other institutional investors.
MASI has been the topic of several recent analyst reports. Stifel Nicolaus reissued a “buy” rating and set a $108.00 price objective (up previously from $105.00) on shares of Masimo Corporation in a research note on Thursday, August 3rd. Zacks Investment Research lowered shares of Masimo Corporation from a “buy” rating to a “hold” rating in a research note on Tuesday, October 3rd. Roth Capital lifted their price objective on shares of Masimo Corporation from $96.00 to $105.00 and gave the stock a “buy” rating in a research note on Wednesday, July 19th. BTIG Research raised shares of Masimo Corporation from a “neutral” rating to a “buy” rating and set a $100.00 price objective on the stock in a research note on Monday, August 14th. Finally, BidaskClub lowered shares of Masimo Corporation from a “hold” rating to a “sell” rating in a research note on Wednesday, August 9th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and five have given a buy rating to the company. Masimo Corporation currently has an average rating of “Hold” and a consensus price target of $97.17.
About Masimo Corporation
Masimo Corporation is a medical technology company that develops, manufactures and markets a range of non-invasive patient monitoring technologies. The Company’s business is Measure-through Motion and Low Perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry.
Receive News & Ratings for Masimo Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo Corporation and related companies with MarketBeat.com's FREE daily email newsletter.